About BioTranex
BioTranex is a company based in Monmouth Junction (United States) founded in 2009 was acquired by Frontage Laboratories in April 2020. BioTranex operates in a competitive market with competitors including Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others.
- Headquarter Monmouth Junction, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Frontage Laboratories
(Apr 22, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of BioTranex
Detailed funding history for BioTranex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in BioTranex
BioTranex has secured backing from 1 investor. Prominent investors backing the company include Frontage Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early drug development services are provided for pharma firms.
|
Locked | Locked | Locked |
Investor details for BioTranex
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BioTranex
Investment portfolio details for BioTranex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BioTranex
Detailed financials for BioTranex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biotranex Comparisons
Peer comparison for BioTranex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BioTranex
BioTranex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Anabios, Clyde Biosciences, Metrion Biosciences, Quiver Bioscience and Zen-Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Ex-vivo human tissue studies are performed for preclinical drug discovery.
|
|
| Locked | Locked | Locked |
Cardiac safety testing is conducted using iPS-derived heart cells.
|
|
| Locked | Locked | Locked |
Ion channel screening and cardiac safety profiling services are provided.
|
|
| Locked | Locked | Locked |
Developer of transformational medicines for neurological disorders
|
|
| Locked | Locked | Locked |
Cell-based solutions are provided to accelerate therapy discovery and development.
|
|
| Locked | Locked | Locked |
Multiplexed immunoassays for protein biomarkers are developed via proprietary platform.
|
Detailed competitors of BioTranex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biotranex
Complete news archive for BioTranex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioTranex
BioTranex was founded in 2009.
BioTranex is headquartered in Monmouth Junction, United States. It is registered at Monmouth Junction, New Jersey, United States.
BioTranex is a preclinical CRO offering comprehensive solutions for DMPK and toxicity testing to drug developers. Their service portfolio includes ADME and DMPK studies, PKPD studies, drug-drug interactions, metabolite interaction studies, human hepatocyte based studies (CYP inhibition and hepatotoxicity studies) and transporter studies. They have special expertise in transporter studies through which they offer patent pending assays namely BSEPcyte (bile salt export pump) and MDR3cyte, which are hepatocyte based platforms which measure the test agent inhibition of BSEP and MDR3.
BioTranex's top competitors include Metrion Biosciences, Quiver Bioscience and Anabios.
BioTranex has 1 investor. Key investors include Frontage Laboratories.